Vetter Pharma
Vetter Pharma, a leading name in the surgical and medical instrument manufacturing industry, is headquartered in Germany (DE) and operates extensively across Europe and North America. Founded in 1950, the company has established itself as a pioneer in the development of high-quality prefilled syringe systems and advanced drug delivery solutions.
Vetter Pharma's core offerings include innovative packaging solutions and contract manufacturing services, which are distinguished by their commitment to precision and reliability. The company has achieved significant milestones, including numerous certifications and partnerships with major pharmaceutical firms, solidifying its position as a trusted provider in the healthcare sector. With a focus on enhancing patient safety and improving therapeutic outcomes, Vetter Pharma continues to lead the way in medical innovation.
+6 vs industry average
Vetter Pharma’s score of 32 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Vetter Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Surgical and Medical Instrument Manufacturing has typical carbon intensity
Industry performance
The Surgical and Medical Instrument Manufacturing industry has reduced its overall emissions by 32% since 2018
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Vetter Pharma's reported carbon emissions
Vetter Pharma, based in Germany and operating in the Surgical and Medical Instrument Manufacturing industry, has reported its carbon emissions for recent years, demonstrating a commitment to climate action.
In 2025, Vetter Pharma's total emissions, encompassing Scope 1 and Scope 3, amounted to approximately 514.87 million kg CO2e. This figure breaks down into Scope 1 emissions of about 18.78 million kg CO2e and Scope 3 emissions of approximately 496.09 million kg CO2e. Purchased goods and services represented the largest portion of Scope 3 emissions, accounting for about 269.42 million kg CO2e.
For 2024, the company reported total emissions of approximately 410.78 million kg CO2e, with Scope 1 emissions at about 16.99 million kg CO2e and Scope 3 emissions at around 393.80 million kg CO2e.
In 2023, total emissions were approximately 288.94 million kg CO2e, comprising about 17.85 million kg CO2e from Scope 1 and 271.09 million kg CO2e from Scope 3.
The company has established significant climate commitments. A near-term goal, currently being validated by the Science Based Targets initiative (SBTi), aims to reduce Scope 1 and 2 greenhouse gas emissions by 58.8% by 2034, using 2021 as the base year. Furthermore, Vetter Pharma is committed to achieving net zero emissions by 2050. As part of its supplier engagement strategy, the company aims for 80% of its suppliers, by spend, in purchased goods and services, capital goods, and upstream transportation and distribution to have science-based targets by 2029.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Vetter Pharma’s Climate Goals (2030 & 2050)
1 goal2050
By 2050, we aim to achieve net zero emissions—a balance of e…
By 2050, we aim to achieve net zero emissions—a balance of emissions that amounts to zero.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Vetter Pharma’s sustainability data and climate commitments
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project